Key result
Molecular adjuvants, such as immunomodulatory proteins, have emerged as promising alternatives to traditional adjuvants to enhance the immune response generated by poultry vaccines.
Why the study?
Vectorized or nucleic acid vaccines in the poultry industry generate low immunogenicity, driving the search for new, safe, and effective adjuvants.
Molecular adjuvants represent a promising alternative to traditional adjuvants for improving the immunogenicity of vectorized or nucleic acid vaccines in poultry.
Answers are grounded in this paper and cite their sources.
New adjuvants needed for low-immunogenicity nucleic acid poultry vaccines; avian immunology advances leave open optimal candidates for testing.
SUMMARYCurrently, vaccination is still the main strategy to prevent important pathologies in the poultry industry. Furthermore, with the growing trend to develop vectorized or nucleic acid vaccines, new obstacles have emerged, for instance, the low immunogenicity this type of vaccine generates. As a consequence, the search for new, safe, and effective adjuvants has taken on greater importance. With the recent advances in avian immunology and genetics, new alternatives to traditional adjuvants have emerged, such as the use of immunomodulatory proteins with the potential to enhance the humoral and cellular immune response generated by vaccines. These recently developed types of adjuvants are named molecular adjuvants. This review summarizes the advances achieved so far using molecular adjuvants to prevent some of the critical diseases in the poultry industry.
No takes yet. Share an insight, caveat, or question.
Escalante-Sansores et al. (2022) conducted a review in Poultry diseases. Molecular adjuvants was evaluated. Molecular adjuvants, such as immunomodulatory proteins, have emerged as promising alternatives to traditional adjuvants to enhance the immune response generated by poultry vaccines.
Synapse has enriched 10 related papers. Consider them for comparative context: